BR

Broadridge Financial Solutions

$181.41

-0.29%
Nov 20, 2026
Bobby Quantitative Model
Broadridge Financial Solutions is a technology and operations provider for the financial services industry, operating through two segments — Investor Communication Solutions (regulatory and proxy communications, fund/retail investor communications, and distribution) and Global Technology and Operations (trade processing, securities finance, and wealth management outsourcing) — serving banks, broker-dealers, asset managers, and corporate issuers. Spun off from Automatic Data Processing in 2007, Broadridge has evolved into a mission-critical utility-like platform with deeply embedded, recurring-revenue relationships and high switching costs, giving it a distinct position as a toll-road operator on capital-markets activity rather than a conventional software vendor. The current investor debate centers on whether AI-driven disruption and fee compression in fund communications threaten its moat, a fear management's strong fiscal Q4 results and forward guidance in early August were seen as rebutting — the stock surged on that print. Since then, the narrative has shifted toward a recovery-and-re-rating story, with shares rebounding sharply off mid-year lows as investors refocus on Broadridge's recurring revenue base, event-driven revenue upside, and resilient cash generation.

People also watch

IBM

IBM

IBM

Analysis
Accenture

Accenture

ACN

Analysis
Cognizant Technology Solutions

Cognizant Technology Solutions

CTSH

Analysis
Fiserv

Fiserv

FISV

Analysis
Fidelity National Information Services

Fidelity National Information Services

FIS

Analysis

BobbyInvestment Opinion: Should I buy BR Today?

Rating: Buy (moderate conviction). The thesis is that Broadridge is a mission-critical, recurring-revenue toll-road on capital-markets activity trading at a trough multiple — 14.16x trailing and roughly 12.3x on the $15.60 consensus EPS — while generating $1.363 billion of TTM free cash flow (an ~8.6% FCF yield) and carrying a consensus 'buy' rating (mean 2.33) with an average target of $209.25, implying +8.7% upside from $192.45. The August 4 earnings-driven surge from $157.34 to $168.41 and the subsequent climb to $192.45 suggest the market is beginning to side with the view that AI-disruption fears were overdone.

Supporting evidence is broad: revenue grew 4.99% year over year to $1.669 billion in Q1 2027 with ~65% recurring fee revenue ($1.083 billion) providing visibility; trailing net margin is 15.04% and operating margin 17.39%, with the seasonally strong Q4 2026 delivering a 38.43% gross margin and $398.1 million of net income; ROE is 39.58% and ROA 9.50%; and the 2.78% dividend yield with a conservative 39.4% payout ratio adds an income dimension rare among technology names. Against a sector that typically trades at 25–35x earnings, the 14.16x trailing PE and 2.13x PS represent a 45–60% discount, and the PEG of 0.406 reinforces the cheapness signal.

The biggest risks that could invalidate the thesis are structural margin compression (Q1 2027 net income halved to $94.8 million from $165.4 million, with gross margin slipping from 26.59% to 25.67%), AI-driven fee compression in fund and proxy communications, and a cyclical drought in event-driven revenue (just $67.4 million in Q1 2027). This Buy would upgrade to higher conviction if gross margin stabilizes above 26% through fiscal Q2 2027 and recurring revenue growth holds near 5%, and would downgrade to Hold if margin compression proves structural or the stock approaches the $209.25 average target without corresponding earnings delivery. On balance the stock is modestly undervalued relative to its own history (PS of 2.13x versus a historical 7.1x–17.7x band) and to sector multiples, though it is fairly valued relative to the near-term analyst consensus.

Sign up to view all

BR 12-Month Price Forecast

The forward-looking case is modestly bullish: a recurring-revenue franchise with a 39.58% ROE and 8.6% FCF yield trades at roughly 12.3x consensus EPS, near the low end of its multi-year valuation band, while analyst sentiment has stabilized at a 'buy' consensus with an $209.25 average target. The August 4 earnings beat and the 32% six-month rally suggest the market is beginning to price out the AI-disruption fear that drove the 42.37% max drawdown. The swing factor is margin trajectory — Q1 2027 net income halved to $94.8 million and gross margin slipped to 25.67%, so confirmation of recovery in the seasonally strong fiscal Q4 is essential. I would upgrade to high confidence if gross margin stabilizes above 26% and recurring revenue growth holds near 5%, and downgrade to neutral if margin compression proves structural or the stock reaches the $209.25 average target without matching earnings delivery.

Historical Price
Current Price $181.41
Average Target $207.50
High Target $233.10
Low Target $160.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Broadridge Financial Solutions's 12-month outlook, with a consensus price target around $209.25 and implied upside of +15.3% versus the current price.

Average Target

$209.25

9 analysts

Implied Upside

+15.3%

vs. current price

Analyst Count

9

covering this stock

Price Range

$180 - $230

Analyst target range

Buy
5 (56%)
Hold
4 (44%)
Sell
0 (0%)

Eight analysts cover Broadridge with a consensus recommendation of "buy" (mean rating 2.33 on a scale where lower is more bullish): 5 Buy, 4 Hold, and 0 Sell. The average target price is $209.25, implying +8.7% upside from the current $192.45, with a range of $180.00 to $230.00 — the current price sits above the low target and about 16% below the high. The consensus leans moderately bullish, but the presence of four Hold ratings and a modest average upside suggests analysts see the stock as fairly valued after its sharp rebound rather than deeply undervalued.

The target range of $180–$230 is relatively tight (about 28% spread from low to high), signaling reasonable conviction rather than wide disagreement. The high target of $230 (roughly +19.5% upside) likely assumes continued multiple re-rating toward historical norms, sustained mid-single-digit revenue growth, and margin recovery in the seasonally strong fiscal Q4, while the low target of $180 (about -6.5% downside) prices in margin compression, AI-driven disruption of fund communications, or a cyclical slowdown in event-driven revenue. Institutional ratings show a stable-to-constructive pattern — RBC Capital reiterating Outperform, DA Davidson and Needham maintaining Buy, and Morgan Stanley, JP Morgan, and UBS holding Neutral — with no downgrades in the recent record, indicating sentiment has stabilized after the mid-year selloff. The consensus revenue estimate of $9.448 billion and EPS estimate of $15.60 provide the fundamental anchor for these targets; the key risk is that the wide gap between the $15.60 consensus EPS and the trailing reported EPS of $0.07 (a data artifact of quarterly seasonality) could confuse valuation screens, but the forward multiple of roughly 12.3x on consensus EPS leaves meaningful room for upside if execution holds.

Drowning in data?

Find the real signal!

Bulls vs Bears: BR Investment Factors

The bull case currently holds the stronger evidence: a 12.3x forward multiple on consensus EPS, an 8.6% FCF yield, 65% recurring revenue, and a 32% six-month rally backed by an August earnings beat that directly rebutted the AI-disruption narrative. The bear case is not weak, however — Q1 2027 net income halved year over year to $94.8 million, gross margin compressed 92 basis points, and the forward PE exceeding the trailing PE implies the market expects earnings to fall from the trailing base. The single most important tension is whether Broadridge's regulatory-utility moat proves durable against AI-enabled fund communications and fee compression; if recurring revenue and margins hold through fiscal 2027, the discount to sector multiples closes and the stock re-rates toward $230, but if margin compression proves structural rather than seasonal, the 14x PE is a value trap rather than a bargain. On balance, the evidence — intact cash generation, stabilizing analyst sentiment, and a stock still 17.4% below its high — tilts modestly bullish, but the margin trajectory is the swing factor that will decide the thesis.

Bullish

  • Deep discount to sector multiples: Broadridge trades at a trailing PE of 14.16x and PS of 2.13x versus a technology sector that typically commands 25–35x earnings — a 45–60% discount. On the $15.60 consensus EPS the forward multiple is roughly 12.3x, remarkably cheap for a business generating a 39.58% ROE and $1.363 billion of trailing free cash flow.
  • Recurring revenue base with high switching costs: Recurring fee revenue of $1.083 billion represented about 65% of Q1 2027's $1.669 billion total, with distribution revenue of $518.2 million and only $67.4 million event-driven. This utility-like mix — regulatory proxy and fund communications embedded in client workflows — provides revenue visibility that justifies a premium, not a discount.
  • Momentum has decisively reversed: The stock is up 32.16% over six months and 14.38% over the past month versus SPY's -2.26%, producing relative strength of +30.03 and +16.64 respectively. The August 4 earnings-driven surge (from $157.34 on August 3 to $168.41 the next session) marked the inflection, and the stock has since climbed to $192.45.
  • Strong cash generation and shareholder returns: TTM free cash flow of $1.363 billion equates to roughly an 8.6% FCF yield on the $15.93 billion market cap, and Q4 2026 alone produced $679.1 million of FCF. Management returned $200.2 million via buybacks and $111.2 million in dividends in Q1 2027 alone, supported by a 2.78% yield and a conservative 39.4% payout ratio.

Bearish

  • Earnings quality deteriorating year over year: Q1 2027 net income fell to $94.8 million from $165.4 million in Q1 2026, and gross margin slipped from 26.59% to 25.67%. The forward PE of 16.63x exceeding the trailing 14.16x implies the market expects earnings to decline from the trailing base — an inversion that signals skepticism about durability.
  • Growth is mature, not accelerating: Revenue grew 4.99% year over year to $1.669 billion in Q1 2027, consistent with a mature franchise rather than a growth story. This mid-single-digit trajectory is precisely why the market applies a discounted multiple versus double-digit-growth software peers, and it limits the scope for multiple expansion without margin improvement.
  • AI disruption threat to fund communications: The core investor debate centers on whether AI-driven automation and fee compression in fund and proxy communications erode Broadridge's moat. The 42.37% max drawdown and 14.70% one-year decline reflect that the market has taken this structural risk seriously, and the low 2.13x PS versus historical 7.1x–17.7x shows how far the de-rating has gone.
  • Leverage limits financial flexibility: Debt-to-equity of 1.238 and a current ratio of 1.236 leave the balance sheet comfortable but not fortress-like, and the 39.58% ROE is flattered by that leverage. Interest expense of $27.1 million in Q1 2027 consumed roughly 25% of the $109.7 million pre-tax income, making the company sensitive to refinancing costs.

BR Technical Analysis

Broadridge is in a recovery uptrend within a longer-term downtrend: the stock is down 14.70% over the past year but has rallied 32.16% over six months and 12.54% over three months, closing at $192.45. That price sits at roughly 59% of the 52-week range of $133.83–$233.10 — meaningfully above the low but still 17.4% below the high, consistent with a stock that has repaired damage but not yet reclaimed its prior peak. The 42.37% max drawdown underscores how severe the mid-2026 selloff was, and the current positioning suggests momentum is rebuilding rather than the stock being overextended.

Short-term momentum is decisively positive and accelerating: the stock is up 14.38% over the past month versus a 2.26% decline in SPY, a relative strength of +16.64 points, and up 12.54% over three months against SPY's -2.83% (relative strength +15.37). This is a sharp reversal from the -14.70% one-year and -12.71% YTD performance, a classic divergence in which near-term strength is repairing longer-term weakness — typically a sign of trend reversal rather than a dead-cat bounce when accompanied by fundamental catalysts, as the August earnings-driven surge suggests. The 6-month relative strength of +30.03 versus SPY confirms sustained outperformance since the summer trough, though the -26.97 one-year relative strength shows how much ground remains to be recovered.

Key technical levels are clear: support sits at the 52-week low of $133.83 (roughly 30% below the current $192.45), with intermediate support likely in the $160–$170 zone that contained the September–October consolidation; resistance is the 52-week high of $233.10, about 21% above the current price. A breakout above the prior high would signal full trend repair and likely invite momentum and growth buyers back, while a breakdown below $160 would undermine the recovery thesis and refocus attention on the $133.83 low. With a beta of 0.898, Broadridge is modestly less volatile than the market — about 10% less — which supports larger position sizing for risk-budgeted portfolios, though the 42.37% drawdown shows that low beta has not insulated shareholders from sharp idiosyncratic selloffs.

Beta

0.90

0.90x market volatility

Max Drawdown

-41.9%

Largest decline past year

52-Week Range

$134-$233

Price range past year

Annual Return

-20.1%

Cumulative gain past year

PeriodBR ReturnS&P 500
1m+1.7%-9.7%
3m-0.4%-9.9%
6m+20.5%-7.5%
1y-20.1%+4.7%
ytd-17.7%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

BR Fundamental Analysis

Revenue is growing at a steady mid-single-digit pace: fiscal Q1 2027 (quarter ended September 30, 2026) revenue was $1.669 billion, up 4.99% year over year from $1.589 billion, continuing a consistent trajectory (Q4 2026: $2.220 billion; Q3 2026: $1.954 billion; Q2 2026: $1.714 billion). The most recent quarter's revenue mix shows recurring fee revenue of $1.083 billion (about 65% of the total), distribution revenue of $518.2 million, and event-driven revenue of $67.4 million — a highly recurring base that provides visibility, with event-driven revenue (proxy contests, corporate actions) acting as cyclical upside. The growth trend is stable rather than accelerating, consistent with a mature, utility-like franchise; the investment case rests more on durability and margin/cash-flow compounding than on top-line acceleration.

Profitability is solid but seasonal: Q1 2027 net income was $94.8 million (net margin 5.68%) on gross margin of 25.67%, versus Q4 2026 net income of $398.1 million (17.93% net margin) and gross margin of 38.43% — the fiscal Q1 is structurally the weakest quarter due to seasonal proxy and event timing. Trailing metrics show a 15.04% net margin, 31.78% gross margin, and 17.39% operating margin, healthy for IT services and reflective of scale economics. Year-over-year, Q1 2027 net income of $94.8 million fell from $165.4 million in Q1 2026, and gross margin slipped from 26.59% to 25.67%, a compression worth monitoring — likely tied to mix and the lower-margin distribution revenue line — though the full-year margin profile remains intact given Q4's 38.43% gross margin.

Cash generation is the franchise's core strength: trailing twelve-month free cash flow is $1.363 billion against a $15.93 billion market cap (roughly 8.6% FCF yield), and Q4 2026 alone produced $679.1 million of FCF on $711.2 million of operating cash flow. The balance sheet carries debt-to-equity of 1.238 and a current ratio of 1.236, with interest coverage of roughly 18.9x in Q4 2026 — comfortable but not fortress-like, and the company actively returns capital ($200.2 million of buybacks and $111.2 million of dividends in Q1 2027 alone). ROE of 39.58% is exceptional, flattered by leverage and a high equity multiplier, while ROA of 9.50% confirms genuine operating returns; the dividend yield of 2.78% with a 39.4% payout ratio leaves ample room for continued growth and buybacks.

Quarterly Revenue

$1.7B

2026-09

Revenue YoY Growth

+5.0%

YoY Comparison

Gross Margin

25.7%

Latest Quarter

Free Cash Flow

$1.4B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Distribution Revenue
Event-Driven Revenue
Recurring Fee Revenue

Open an Account, get $2 TSLA now!

Valuation Analysis: Is BR Overvalued?

Because net income is positive, the PE ratio is the primary metric: the trailing PE is 14.16x against a forward PE of 16.63x — an unusual inversion in which the forward multiple exceeds the trailing one, implying the market expects earnings to decline from the trailing base (trailing EPS is distorted upward by a strong fiscal Q4 2026 of $3.44). On the analyst consensus EPS estimate of $15.60 for the forward period, the stock trades at roughly 12.3x, which is remarkably low for a high-ROE, recurring-revenue franchise — suggesting either a value opportunity or skepticism about earnings durability. The PEG ratio of 0.406 reinforces the cheapness signal, though it should be treated cautiously given the earnings seasonality.

Relative to the Technology sector and IT services peers, Broadridge screens cheap on most multiples: PS of 2.13x, EV/Sales of 3.32x, EV/EBITDA of 11.60x, and PCF of 11.84x, with a PB of 5.61x that is elevated only because of the high ROE and leverage. A trailing PE of 14.16x versus a sector that typically trades in the 25–35x range represents a substantial discount — roughly 45–60% below typical software/services multiples — which the market justifies with mid-single-digit growth (4.99% YoY) rather than the double-digit growth of premium peers. The 2.78% dividend yield and 39.4% payout ratio add an income dimension rare among technology names, supporting the case that the discount reflects growth maturity rather than distress.

Historically, Broadridge's own valuation band has been far higher: PE ratios in the historical data ranged from roughly 9.9x (Q4 2026) to 114x (Q2 2022), with most quarters between 17x and 48x, and PS ratios ranged from about 7.1x to 17.7x versus the current 2.13x. The current trailing PE of 14.16x sits near the low end of its multi-year range, and the PS of 2.13x is dramatically below historical levels — a compression that partly reflects the stock's 14.70% one-year decline and partly the earnings mix. Near-historical-low multiples can signal either a genuine value opportunity (if the recurring revenue base and FCF are intact, which they appear to be) or structural de-rating from AI/disruption fears; the August earnings beat and subsequent 32% six-month rally suggest the market is beginning to side with the former.

PE

14.2x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 10x~114x

vs. Industry Avg

19.1x

Industry PE ~19.1x*

EV/EBITDA

11.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on margin compression and earnings seasonality. Q1 2027 net income of $94.8 million fell sharply from $165.4 million a year earlier, and gross margin declined from 26.59% to 25.67%, a trend that if extended through the seasonally strong Q4 (which delivered a 38.43% gross margin and $398.1 million of net income in fiscal 2026) would materially undercut the full-year profile. The revenue mix compounds this: distribution revenue of $518.2 million is lower-margin and grew as a share of the $1.669 billion total, diluting blended profitability, while event-driven revenue of just $67.4 million is inherently cyclical and can vanish in a quiet proxy season. Leverage of 1.238x debt-to-equity and a 1.236 current ratio are manageable but leave limited cushion, with $27.1 million of quarterly interest expense consuming roughly a quarter of pre-tax income.

Market and competitive risks are dominated by the AI-disruption debate and valuation compression. The stock's 42.37% max drawdown and 14.70% one-year decline show the market has already priced in meaningful structural fear, yet at 14.16x trailing and 16.63x forward earnings the multiple could compress further if fee compression in fund communications accelerates. With a beta of 0.898 the stock is about 10% less volatile than the market, but that low beta did not insulate shareholders from the idiosyncratic mid-2026 selloff, and the -26.97 one-year relative strength versus SPY shows how far it has lagged. The August 4 earnings-driven surge — shares jumped from $157.34 to $168.41 in a single session — also creates event risk in reverse: a single disappointing print could retrace that gain just as quickly, and four of eight analysts sitting at Hold with an average target only 8.7% above the current price limits the cushion from further downgrades.

In a worst-case scenario, a combination of structural margin compression, AI-driven loss of fund-communication share, and a cyclical drought in event-driven revenue would compress earnings while the multiple de-rates toward the low end of its historical band. The 52-week low of $133.83 represents roughly -30% from the current $192.45, and the analyst low target of $180 implies about -6.5%; a retest of the low would mean a loss of approximately 30% for current holders, consistent with the 42.37% max drawdown already experienced. A more moderate adverse case — a miss on fiscal Q2 2027 earnings that confirms margin erosion — would likely take the stock back to the $160–$170 consolidation zone, a decline of roughly 12–17%, before the $133.83 floor comes into play.

FAQ

The most severe risk is financial: margin compression, with Q1 2027 net income falling to $94.8 million from $165.4 million and gross margin slipping from 26.59% to 25.67%, which if it extends through the seasonally strong fiscal Q4 would break the full-year earnings profile. Second is competitive and structural — AI-enabled automation and fee compression in fund and proxy communications threaten the moat, a fear already reflected in the 42.37% max drawdown and 14.70% one-year decline. Third is cyclical: event-driven revenue of just $67.4 million in Q1 2027 can dry up in a quiet proxy season, and distribution revenue of $518.2 million dilutes blended margins. Fourth is company-specific and balance-sheet related — debt-to-equity of 1.238 and $27.1 million of quarterly interest expense consuming roughly a quarter of pre-tax income leave limited flexibility, while four of eight analysts at Hold with only 8.7% average upside limits the cushion against downgrades.

The 12-month forecast splits into three scenarios. The base case (50% probability) targets $200–$215, aligned with the $209.25 analyst average, assuming mid-single-digit revenue growth, gross margin recovery in fiscal Q4, and a multiple holding in the low-to-mid teens. The bull case (25%) targets $225–$233.10, requiring a re-rating toward 17x–20x forward earnings as AI-disruption fears fade and the stock reclaims its 52-week high. The bear case (25%) targets $160–$180, with the $133.83 52-week low as the floor, driven by structural margin compression and a quiet proxy season. The base case is most likely, and its key assumption is that the Q1 2027 margin slip proves seasonal rather than structural — confirmation of that in fiscal Q2 2027 would tilt the distribution toward the bull case.

BR screens undervalued on most absolute and relative measures. The trailing PE of 14.16x, PS of 2.13x, EV/EBITDA of 11.60x, and PEG of 0.406 all sit well below a technology sector that typically commands 25–35x earnings, a roughly 45–60% discount. Against its own history the gap is even wider: PS ratios historically ranged from about 7.1x to 17.7x versus 2.13x today, and the trailing PE sits near the low end of a multi-year band that has mostly run between 17x and 48x. The market is therefore pricing in mature mid-single-digit growth (4.99% year over year) and skepticism about earnings durability rather than distress, since free cash flow of $1.363 billion and a 39.58% ROE remain intact. The unusual inversion of forward PE (16.63x) above trailing PE (14.16x) signals the market expects earnings to fall from the trailing base, which is the key assumption embedded in the current price.

From a risk/reward standpoint, BR offers a favorable but not exceptional setup: at $192.45 it trades at 14.16x trailing and roughly 12.3x consensus EPS of $15.60, with an 8.6% FCF yield and a consensus 'buy' rating (mean 2.33) carrying an average target of $209.25 — about +8.7% upside. The downside is bounded by the $180 analyst low target (-6.5%) and, in a severe case, the $133.83 52-week low (-30%), so the asymmetry is modestly positive rather than compelling. The biggest risk is that Q1 2027 net income halved to $94.8 million and gross margin slipped to 25.67%, which if structural would make the cheap multiple a value trap. It is a good buy for income-oriented, risk-budgeted investors seeking a 2.78% yield plus recurring-revenue durability, and less attractive for those demanding large near-term upside after the 32.16% six-month rally.

BR is better suited to long-term holding than short-term trading. It is a mature, mid-single-digit-growth franchise with a beta of 0.898, a 2.78% dividend yield, and a 39.4% payout ratio, and its earnings are highly seasonal — fiscal Q1 is structurally the weakest quarter (5.68% net margin) while fiscal Q4 delivers the bulk (17.93% net margin and 38.43% gross margin) — so quarterly prints can be noisy and misleading for traders. The 42.37% max drawdown and 14.70% one-year decline show that even a low-beta name can suffer sharp idiosyncratic selloffs, which argues against leveraged or short-horizon positioning. A minimum holding period of 12–24 months is appropriate to capture a full fiscal cycle and any multiple re-rating toward historical norms, with the 2.78% yield providing a modest carry along the way. Short-term traders could play the recovery momentum (+14.38% in one month versus SPY's -2.26%), but that is a tactical trade, not the core thesis.